Article
Self-Monitoring of Blood Glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research.
Department of Medicine, University of Washington Medical Center-Roosevelt, Seattle, Washington 98105, USA.
Diabetes Technology & Therapeutics (impact factor:
1.93).
11/2008;
10(6):419-39.
DOI:10.1089/dia.2008.0104
Source: PubMed
-
Citations (0)
- Cited In (4)
-
Article: Self-monitoring of blood glucose during pregnancy: Indications and limitations.
[show abstract] [hide abstract]
ABSTRACT: Self-monitoring of blood glucose (SMBG) is an important tool to treat diabetes during pregnancy. However, proper implementation of SMBG in pregnant women requires understanding of its applications and limitations. This article reviews issues related to the implementation, efficacy, and accuracy of SMBG and discusses factors that can confound results of SMBG during pregnancy.Diabetology and Metabolic Syndrome 12/2012; 4(1):54. · 1.53 Impact Factor -
Article: Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulin.
[show abstract] [hide abstract]
ABSTRACT: To assess the effect of an Internet-based glucose monitoring system (IBGMS) on A1C levels in patients with type 2 diabetes treated with insulin. This trial involved 50 patients randomly assigned to receive either conventional treatment alone or with additional follow-up through an IBGMS for 6 months. Patients randomized to the intervention group uploaded blood glucose readings every 2 weeks to a secure Web site for review and receipt of feedback from their endocrinologist. A1C and laboratory test results were collected at 0, 3, and 6 months. The baseline parameters were not significantly different. Over a 6-month follow-up, A1C dropped from 8.8 to 7.6% (P < 0.001) in the intervention group compared with 8.5 to 8.4% (P = 0.51) in the control group. The use of IBGMS significantly improved A1C levels in patients with type 2 diabetes treated with insulin.Diabetes care 08/2010; 33(8):1738-40. · 8.09 Impact Factor -
Article: Actionable self-monitoring of blood glucose: redefining the role for patients using multiple daily injection therapy.
[show abstract] [hide abstract]
ABSTRACT: Self-monitoring of blood glucose (SMBG) values is an accepted requirement for patients with diabetes using multiple daily injections of insulin. Nevertheless, for many patients, the full value of SMBG has yet to be realized due to a number of factors that contribute to patients not taking appropriate action based on the achieved result. The reasons for this are complex but are related to the burden imposed by performing the tests, the need for complex numerical calculations, and the demand for undertaking this activity multiple times each day. In the near future, SMBG devices are likely to include technological innovations that are aimed at overcoming these barriers, offering "actionable" SMBG for patients using insulin. These innovations should include technologies that will allow customization and individualization based upon specific therapy regimens.Journal of diabetes science and technology 11/2011; 5(6):1584-90.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
blood glucose
Current clinical guidelines
diabetes care
diabetes nurse practitioner
discern optimal models
future studies
glycemic control
health psychologist
long-term benefits
lower complication-related costs
monitoring equipment
multidisciplinary group
non-insulin-using patients
real-world conditions
research considerations
review article
Specific protocols
test results
today's healthcare environment
use insulin